Navigation Links
Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
Date:3/23/2009

Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

VOORHEES, N.J., March 23 /PRNewswire/ -- The epidemiology of Clostridium difficile infection (CDI) is changing rapidly and has been marked by a significant increase in incidence and severity. Management of CDI can be challenging and guidelines for treatment and prevention are being updated. In order to effectively implement key strategies for reducing the incidence and severity of this virulent pathogen, it is crucial for primary care physicians to have current education on CDI.

To address the need for education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen. The content for this virtual lecture was developed from a live satellite symposium held during Pri-Med East 2008. This activity is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians.

Faculty for this continuing education virtual lecture include Frank Friedenberg, MD, MS (Epi), Associate Professor of Medicine in the Department of Gastroenterology at Temple University School of Medicine in Philadelphia, Pennsylvania; Stuart Johnson, MD, DTM&H, Associate Professor of Medicine at Loyola University Medical Center, Stritch School of Medicine in Maywood, Illinois, and Staff Physician at Hines VA Hospital in Hines, Illinois; and Linda M. Mundy, MD, Adjunct Assistant Professor in the Department of Community Health at Saint Louis University School of Public Health in St. Louis, Missouri, and Healthcare Consultant with LM Mundy, LLC, in Philadelphia, Pennsylvania.

Healthcare professionals can visit http://cmsprepub.medscape.com/viewprogram/18782 to participate in this continuing education virtual lecture.

"Robert Michael Educational Institute LLC recognizes that continuing education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE RMEI
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Interview with GI Experts: Discussions in Clostridium difficile
2. Clostridium difficile Infection: Best Strategies for Care of Older Adults
3. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
4. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
5. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
6. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
7. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
8. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
9. Advances in C. difficile research
10. APIC Launches First National C. Difficile Prevalence Study
11. APIC launches first national C. difficile prevalence study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... this installment is bolstered by inspiring human interest stories, courtesy of leaders in ... trends and tech within the industry, from leading advocates and associations—namely Jones & ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... to support the company’s continued investment and strategic growth plans in the Asia ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: